INMUSER CP
INMUSER CP
Authorised
- Immunoglobulins against Clostridium perfringens epsilon toxoid, Equine
Product identification
Medicine name:
INMUSER CP
Active substance:
- Immunoglobulins against Clostridium perfringens epsilon toxoid, Equine
Target species:
-
Sheep
-
Goat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Immunoglobulins against Clostridium perfringens epsilon toxoid, Equine120.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Sheep
-
Meat and offal0day
-
- Goat
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AM02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Package description:
- Available only in Spanish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Ovejero S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.
Responsible authority:
- The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 3278 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
How useful was this page?:
